MedTrace Logo

A Treatment for Severe Inflammatory Acne Subjects

NCT02899000 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 186

Last updated 2022-12-09

Study results available
· View outcomes & findings →

Summary

Demonstrate that a daily treatment regimen of adapalene 0.3%/benzoyl peroxide 2.5% gel + oral Doxycycline 200 mg is effective and safe in severe inflammatory acne with 3 or fewer nodules or cysts (non-nodulocystic) during a 12-week treatment period.

Conditions

  • Acne Vulgaris

Interventions

DRUG

Adapalene 0.3% / benzoyl peroxide 2.5% emulsion gel

Topical acne therapy

DRUG

Oral doxycycline hyclate

Tetracycline-class oral antibacterial 200 mg daily (2 tablets \[50 mg\], twice daily)

Sponsors & Collaborators

  • Galderma R&D

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-29
Primary Completion
2017-03-28
Completion
2017-06-27

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02899000 on ClinicalTrials.gov